With us today is Reg Hislop. Reg is a healthcare executive, consultant, and managing Partner at H2 Healthcare, LLC a full-service advisory firm specializing in health care and the post-acute care industry.
On March 10, the Centers for Medicare & Medicaid Services (CMS) took further action to ensure patients have access to the critical healthcare services they need in the wake of the 2019 Novel Coronavirus (COVID-19) outbreak. Following a meeting with President Trump and Vice President Pence, many leading insurance companies and their industry associations announced they will be treating COVID-19 diagnostic tests as covered benefits and will be waiving cost sharing that would otherwise apply to the test. The President also directed CMS to provide more flexibility to Medicare Advantage and Part D plans to ensure they have the tools they need to provide seniors with the best coverage. As a result, CMS published a memorandum to Medicare Advantage (MA) and Part D health and prescription drug plans informing them of the flexibilities they have to provide healthcare coverage to Medicare beneficiaries for COVID-19 testing, treatments, and prevention.
CMS is delaying the Minimum Data Set (MDS) 3.0 v1.18.1 release, which had been scheduled for October 1, 2020, in response to stakeholder concerns. The MDS item sets are used by Nursing Home and Swing Bed providers to collect and submit patient data to CMS. This MDS data informs payment, quality, and the survey process.
The Trump Administration released new tools to strip away regulatory red tape and unleash new resources to support state Medicaid and Children’s Health Insurance Programs (CHIP) during the 2019 Novel Coronavirus (COVID-19) outbreak. Because of the President’s bold action in declaring COVID-19 a national emergency, CMS now has a full suite of tools available to maximize responsiveness to state needs. The agency has created four checklists that together will make up a comprehensive Medicaid COVID-19 federal authority checklist to make it easier for states to receive federal waivers and implement flexibilities in their program.
In order to address provider’s concerns regarding COVID-19, we have created a coronavirus forum where providers can connect with one another. The forum can include topics such as supplies, visitation, concerns, regulations, mandates, infection control, payment, staffing, etc. You’re not alone in this, we have you covered. Visit the forum to post questions, concerns, and tips and receive input from other providers across the nation. Join here.
As COVID-19 spreads throughout the U.S., LTC providers face unique challenges to keep their high-risk residents safe. In an effort to fully understand the challenges SNFs are currently facing as a result of the virus, we’d like readers to complete a survey to tell us about their challenges.
The Centers for Medicare & Medicaid Services (CMS) issued frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the 2019-Novel Coronavirus (COVID-19).
One quarter down, and PDPM appears to be mostly positive for SNFs. CMS is reporting a higher average per diem payment level than under RUGs. Despite some added coding complexity, paperwork burdens are down for providers (for example, we have two MDSs during most stays now vs. many more under RUGs).